249 related articles for article (PubMed ID: 12575540)
21. Erythrocyte peroxide metabolism, plasma lipid pattern and hemorheological profile in chronic renal failure.
Caimi G
J Nephrol; 2002; 15(2):104-8. PubMed ID: 12018624
[TBL] [Abstract][Full Text] [Related]
22. [Uremic plasma as cause of metabolic changes in red blood cells].
Eggert W; Schmidt G; Devaux S
Z Urol Nephrol; 1981 Feb; 74(2):141-7. PubMed ID: 7223096
[TBL] [Abstract][Full Text] [Related]
23. [Effect of hemodialysis and hemosorption on blood serum level of medium-molecular components in patients with chronic renal failure].
Kozlov VV; Riabov SI; Dorofeeva TB; von Appen K; Spiridonov VN
Ter Arkh; 1984; 56(7):77-81. PubMed ID: 6484840
[No Abstract] [Full Text] [Related]
24. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.
Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V
Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119
[TBL] [Abstract][Full Text] [Related]
25. Changes in red blood cell membrane structure in patients with chronic renal failure.
Gwoździński K; Janicka M; Brzeszczyńska J; Luciak M
Acta Biochim Pol; 1997; 44(1):99-107. PubMed ID: 9241360
[TBL] [Abstract][Full Text] [Related]
26. [Erythrocyte in pathology: speculations at the electron microscope].
Riazantseva NV; Novitskiĭ VV; Stepovaia EA; Tkachenko CB
Arkh Patol; 2004; 66(3):53-61. PubMed ID: 15318561
[TBL] [Abstract][Full Text] [Related]
27. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis.
Ronco C; Brendolan A; Winchester JF; Golds E; Clemmer J; Polaschegg HD; Muller TE; La Greca G ; Levin NW
Blood Purif; 2001; 19(2):260-3. PubMed ID: 11150821
[No Abstract] [Full Text] [Related]
28. [Hyperprebetalipoproteinemia in patients treated by hemodialysis: clinico-experimental study].
Notarbartolo A; Stalteri A; Averna MR; Picone G; Piovana U; Montalto G; Battianati E; De Simone M
G Clin Med; 1980 May; 61(5):386-401. PubMed ID: 7450358
[No Abstract] [Full Text] [Related]
29. [Changes in the lipid content of erythrocytes in patients with chronic renal failure].
Witkowska J; Bober J; Chlubek D
Ann Acad Med Stetin; 2007; 53(2):46-51. PubMed ID: 18557376
[TBL] [Abstract][Full Text] [Related]
30. Plasma amino acid profile and L-arginine uptake in red blood cells from malnourished uremic patients.
Reis PF; da Silva CD; Brunini TM; Moss MB; Siqueira MA; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
J Ren Nutr; 2006 Oct; 16(4):325-31. PubMed ID: 17046616
[TBL] [Abstract][Full Text] [Related]
31. [Possibility of recovery with the aid of periodic extracorporeal dialysis in patients with chronic renal insufficiency in the terminal phase. Considerations on a case].
Buoncristiani U; Timio M; Innocenti P
Minerva Nefrol; 1971; 18(3):170-8. PubMed ID: 5115762
[No Abstract] [Full Text] [Related]
32. [Scanning electron microscopy in the assessment of erythrocyte shape in peripheral blood of patients with anthracotic tuberculosis and pulmonary tuberculosis].
Kryzhanovskiĭ DG; Kozhushko MIu
Probl Tuberk; 1995; (3):49-50. PubMed ID: 7617638
[TBL] [Abstract][Full Text] [Related]
33. [Changes in the activity of the blood antioxidant enzymes during hemodialysis of patients with terminal kidney failure].
Bogdan GM; Sizykh TP; Saifutdinov RG; Matveev VN
Ter Arkh; 1995; 67(12):37-9. PubMed ID: 8820055
[TBL] [Abstract][Full Text] [Related]
34. [Methods of extracorporeal detoxication in phthisiologic patients with chronic renal failure].
Dzhunusbekov AD; Muratkhanov EZh; Abdukarimov KhKh; Imangaliev NK; Kazykhanova BR
Probl Tuberk; 1987; (8):60-4. PubMed ID: 3684994
[No Abstract] [Full Text] [Related]
35. Chronic renal disease patients with severe star fruit poisoning: hemoperfusion may be an effective alternative therapy.
Chen LL; Fang JT; Lin JL
Clin Toxicol (Phila); 2005; 43(3):197-9. PubMed ID: 15902795
[TBL] [Abstract][Full Text] [Related]
36. Reduced blood bcl-2 protein concentration in patients on hemodialysis.
Buemi M; Allegra A; Corica F; Ruello M; Di Pasquale G; Aloisi C; Giaccobe MS; Romeo A; Frisina N
Blood Purif; 1998; 16(6):312-6. PubMed ID: 10343077
[TBL] [Abstract][Full Text] [Related]
37. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].
Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ
Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495
[TBL] [Abstract][Full Text] [Related]
38. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment.
Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D
Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465
[TBL] [Abstract][Full Text] [Related]
39. [Electromyography in patients in the terminal stages of chronic renal failure treated with regular hemodialysis and hemosorption].
Ender LA; Lagutina TS; Cherniakov VL; Shcherbakova EO; Shcherbakov VA
Urol Nefrol (Mosk); 1984; (5):57-62. PubMed ID: 6095507
[No Abstract] [Full Text] [Related]
40. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
Trznadel K; Kidawa Z; Walasek L; Lutz W
Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
